Ricerca avanzata

Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2016 Marzo;41(1) > Minerva Endocrinologica 2016 Marzo;41(1):122-37



Rivista sulle Malattie del Sistema Endocrino

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118

Periodicità: Trimestrale

ISSN 0391-1977

Online ISSN 1827-1634


Minerva Endocrinologica 2016 Marzo;41(1):122-37


Pre-existing diabetes in pregnancy

Suja PADMANABHAN 1, 2, Monica ZEN 3, Vincent LEE 2, 4, 5, Ngai W. CHEUNG 1, 2

1 Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia; 2 School of Medicine, University of Sydney, Sydney, Australia; 3 Department of Obstetrics and Gynecology, Westmead Hospital, Sydney, Australia; 4 Department of Renal Medicine, Westmead Hospital, Sydney, Australia; 5 Centre for Transplant and Renal Research, Westmead Millennium Institute, Sydney, Australia

The incidence of type 1 and type 2 diabetes amongst women of reproductive age is increasing worldwide. Despite recent advances in treatment options for diabetes outside of pregnancy, women still have a significantly increased risk of adverse obstetric outcomes including perinatal death and congenital malformation, compared to the non-diabetic population. An understanding of the physiological changes during pregnancy, management, early detection and prevention of complications and pre-pregnancy care, specific to women with pre-existing diabetes, is important in improving health outcomes in this growing group of women. This review particularly focuses on areas where there have been recent developments or controversy.

lingua: Inglese


inizio pagina